Alisse Hauspurg

Alisse Hauspurg

Auto-generated profile, based on publicly available information

Alisse Hauspurg

Warren Alpert Medical School at Brown University Providence Rhode Island USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2021 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
AHAlisse Hauspurg
Alisse Hauspurg
AJArun Jeyabalan
Arun Jeyabalan

18 February 2025 in Circulation
Verified
Journal Article
Closed access
MCMalamo Countouris
Malamo Countouris
ZMZainab Mahmoud
Zainab Mahmoud
JCJordana B. Cohen
Jordana B. Cohen
DCDaniela Crousillat
Daniela Crousillat
AHAfshan B. Hameed
Afshan B. Hameed
NBNatalie A. Bello
Natalie A. Bello
Hypertension in pregnancy contributes substantially to maternal morbidity and mortality, persistent hypertension, and rehospitalization. Hypertensive disorders of pregnancy are also associated with a heightened risk of cardiovascular disease, and timely recognition and modification of associated risk factors is crucial in optimizing long-term maternal health. During pregnancy, there are expected physiologic alterations in blood pressure (BP); however, pathophysiologic alterations may also occur, leading to preeclampsia and gestational hypertension. The diagnosis and effective management of hypertension during pregnancy is essential to mitigate maternal risks, such as acute kidney injury, stroke, and heart failure, while balancing potential fetal risks, such as growth restriction and preterm birth due to altered uteroplacental perfusion. In the postpartum period, innovative and multidisciplinary care solutions that include postpartum maternal health clinics can help optimize short- and long-term care through enhanced BP management, screening of cardiovascular risk factors, and discussion of lifestyle modifications for cardiovascular disease prevention. As an adjunct to or distinct from postpartum clinics, home BP monitoring programs have been shown to improve BP ascertainment across diverse populations and to lower BP in the months after delivery. Because of concerns about pregnant patients being a vulnerable population for research, there is little evidence from trials examining the diagnosis and treatment of hypertension in pregnant and postpartum individuals. As a result, national and international guidelines differ in their recommendations, and more studies are needed to bolster future guidelines and establish best practices to achieve optimal cardiovascular health during and after pregnancy. Future research should focus on refining treatment thresholds and optimal BP range peripartum and postpartum and evaluating interventions to improve postpartum and long-term maternal cardiovascular outcomes that would advance evidence-based care and improve outcomes worldwide for people with hypertensive disorders of pregnancy.

1 September 2019 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
AHAlisse Hauspurg
Alisse Hauspurg
SPSamuel Parry
Samuel Parry
BMBrian M. Mercer
Brian M. Mercer
WGWilliam Grobman
William Grobman
THTamera Hatfield
Tamera Hatfield
HSHyagriv Simhan
Hyagriv Simhan

1 October 2019 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
AHAlisse Hauspurg
Alisse Hauspurg
LLLara S. Lemon
Lara S. Lemon
BQBeth A. Quinn
Beth A. Quinn
ABAnna Binstock
Anna Binstock
JLJacob Larkin
Jacob Larkin
HSHyagriv N. Simhan
Hyagriv N. Simhan
OBJECTIVE: To evaluate the feasibility, acceptability, and compliance of a remote blood pressure monitoring protocol implemented as a quality improvement measure at the hospital level for management of hypertension in postpartum women after hospital discharge. METHODS: This is an ongoing quality improvement project that included women admitted to the postpartum unit of a single tertiary care hospital. We designed nursing call center-driven blood pressure management and treatment algorithms, which were initiated after hospital discharge until 6 weeks postpartum. Women are eligible to participate if they have a diagnosis of chronic hypertension, superimposed preeclampsia, gestational hypertension, preeclampsia, or postpartum hypertension and have access to a text messaging-enabled smartphone device. After identification by an obstetric care provider, women are enrolled into the program, which is automatically indicated in the electronic medical record. Maternal, obstetric, and sociodemographic data were obtained from the electronic medical record. RESULTS: Between February 2018 and January 2019, we enrolled 499 patients. Here we report on the first 409 enrolled patients. Participants include 168 (41%) with gestational hypertension, 179 (44%) with preeclampsia with no history of chronic hypertension, 49 (12%) with chronic hypertension with superimposed preeclampsia, and 13 (3%) with postpartum preeclampsia. One hundred seventy-one (42%) participants had antihypertensives initiated or titrated through the program. Three hundred forty women (83%) continued the program beyond 3 weeks postpartum, and 360 (88%) attended an in-person 6-week postpartum visit. Two hundred thirty-five out of 250 women who completed a postprogram survey (94%) reported satisfaction with the program. CONCLUSION: In this study, we detail results from an ongoing remote blood pressure monitoring program. We demonstrate high compliance, retention, and patient satisfaction with the program. This is a feasible, scalable remote monitoring program connected to the electronic medical record.

1 December 2020 in JAMA Network Open
Verified
Journal Article
Closed access
PDF file
AHAlisse Hauspurg
Alisse Hauspurg
LLLara Lemon
Lara Lemon
CCCamila Cabrera
Camila Cabrera
AJAmal Javaid
Amal Javaid
ABAnna Binstock
Anna Binstock
HSHyagriv Simhan
Hyagriv Simhan
Recent evidence suggests that maternal morbidity and mortality are increasing in the United States, most of which occur in the 6 weeks after delivery, referred to as the “fourth trimester.”1 The cause of this increase is likely multifactorial, associated with advancing maternal age and medical comorbidities as well as the concomitant limitations of the health care system. Recent data from the Centers for Disease Control and Prevention2 demonstrate that Black women are 3 to 4 times more likely to die in childbirth compared with women of other races/ethnicities, a finding that persists across socioeconomic strata and is thought to be associated with social determinants of health as well as implicit and explicit biases within the health care system, resulting in inequitable treatment.1,3,4

1 November 2019 in Obstetrics & Gynecology
Verified
Journal Article
Closed access
EREmily K. Redman
Emily K. Redman
AHAlisse Hauspurg
Alisse Hauspurg
CHCarl A. Hubel
Carl A. Hubel
JRJames M. Roberts
James M. Roberts
AJArun Jeyabalan
Arun Jeyabalan
OBJECTIVE: To identify clinical risk factors associated with development of delayed-onset postpartum preeclampsia, and to characterize management and subsequent risk of cardiovascular disease. METHODS: This is a case–control study of women admitted to the hospital with delayed-onset postpartum preeclampsia (defined as a new diagnosis of preeclampsia presenting between 48 hours and 6 weeks postpartum) compared with women with full-term, uncomplicated pregnancies without a hypertensive diagnosis or diabetes. Included women delivered between January 2014 and June 2018 at a single tertiary care center. Women with an antenatal diagnosis of preeclampsia or chronic hypertension were excluded. Univariate analysis was used to identify risk factors associated with delayed-onset postpartum preeclampsia and to compare rates of hypertension and antihypertensive medication use, with follow-up beyond 3 months postpartum among a subset of women in the control group who were matched 2:1 with women in the case group. Multivariable logistic regression was performed and included covariates identified in a backward stepwise approach. RESULTS: Compared with women in the control group (n=26,936), women with delayed-onset postpartum preeclampsia (n=121) were significantly more likely to be of non-Hispanic black race (31.4% vs 18.0%), obese (39.7% vs 20.1%), and deliver by cesarean (40.5% vs 25.8%), all P<.01. For women diagnosed with delayed-onset postpartum preeclampsia, the median postpartum day of presentation was 7.0 (interquartile range 5.0–9.0), with 93.4% presenting secondary to symptoms, which was most commonly a headache. A majority (73.6%) underwent imaging studies, and 49.6% received intravenous antihypertensive agents. A total of 86 (71.0%) women with delayed-onset postpartum preeclampsia and 169 (72.8%) women in the control group had longer term information available, with a median follow-up time of 1.5 years (interquartile range 0.8–2.8). Delayed-onset postpartum preeclampsia was associated with higher blood pressures at 3 months postpartum or later (median systolic 130 mm Hg vs 112 mm Hg and median diastolic 80 mm Hg vs 70 mm Hg, P<.001). CONCLUSION: Delayed-onset postpartum preeclampsia is associated with variable management strategies. There is substantial overlap between the clinical risk factors for delayed-onset postpartum preeclampsia and antepartum preeclampsia. Our findings suggest that delayed-onset postpartum preeclampsia is also associated with an increased risk of progression to chronic hypertension.